Emotional health and immunotherapy for liver cancer
Part of Cancer, Digestive system clinical trials.
This trial studies how emotional well-being affects how well immunotherapy works for liver cancer. It is for people newly diagnosed with liver cancer who have not yet been treated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Between 18 and 75 years old
- Newly diagnosed with liver cancer (hepatocellular carcinoma or intrahepatic cholangiocarcinoma) and not yet treated
- Have at least one tumor that can be seen on a CT scan
- Good liver function (Child-Pugh score 7 or less) and good overall health (ECOG score 0 or 1)
- No serious heart, lung, brain, or other major organ conditions
- No current or past other cancers, no severe psychiatric disorders, and not taking antidepressants or anti-anxiety medications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a type of talking therapy (called cognitive behavioral therapy, or CBT) can help people with liver cancer who also feel depressed or anxious. It aims to improve your mood and quality of life.
This trial studies how liver cancer changes during immunotherapy and looks for biological markers that may predict treatment response. It helps doctors understand why some patients benefit more from treatment.
This trial studies if emotional health affects how well targeted therapy and immunotherapy work for people with advanced liver cancer. You will receive chemotherapy directly into the liver along with targeted drugs and immunotherapy.
This study looks at how emotional stress affects how well immunotherapy works for liver cancer. It is for people with liver cancer who are about to start immunotherapy, either before or after surgery, or as first treatment for advanced cancer.
This trial tests immunotherapy-based combinations for liver cancer. It may help if your doctor thinks this treatment could benefit you.
This study looks at how your immune cells respond to two specific immunotherapy-based treatments for advanced liver cancer. Researchers want to understand why some patients respond well and others do not, which could help improve future care.
Hear when a new Liver Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.